These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 212170)

  • 1. Clinical research on the treatment of locally advanced lung cancer: final report of VALG Protocol 13 Limited.
    Petrovich Z; Ohanian M; Cox J
    Cancer; 1978 Sep; 42(3):1129-34. PubMed ID: 212170
    [No Abstract]   [Full Text] [Related]  

  • 2. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P; Barrelet L; Chapuis B; Garcia B
    Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
    [No Abstract]   [Full Text] [Related]  

  • 3. CCNU-adriamycin therapy in bronchogenic carcinoma.
    Trowbridge RC; Kennedy BJ; Vosika GJ
    Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical report of the treatment of locally advanced lung cancer.
    Petrovich Z; Mietlowski W; Ohanian M; Cox J
    Cancer; 1977 Jul; 40(1):72-7. PubMed ID: 195709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced lung cancer: A clinical trial of radiotherapy plus two drug combination regimens.
    van der Merwe AM; Falkson G; Sandison AG; van Dyk JJ; Falkson HC
    S Afr Med J; 1973 Nov; 47(46):2219-22. PubMed ID: 4357406
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of lung cancer.
    Zubrod CG; Selawry O
    Adv Intern Med; 1978; 23():451-67. PubMed ID: 204171
    [No Abstract]   [Full Text] [Related]  

  • 7. Oat cell carcinoma of the lung: combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate.
    Wittes RE; Hopfan S; Hilaris B; Golbey RB; Melamed M; Martini N
    Cancer; 1977 Aug; 40(2):653-9. PubMed ID: 196737
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis.
    Hreshchyshyn MM; Aron BS; Boronow RC; Franklin EW; Shingleton HM; Blessing JA
    Int J Radiat Oncol Biol Phys; 1979 Mar; 5(3):317-22. PubMed ID: 110744
    [No Abstract]   [Full Text] [Related]  

  • 9. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
    Takita H; Marabella PC; Edgerton F; Rizzo D
    Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
    [No Abstract]   [Full Text] [Related]  

  • 10. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung.
    Edmonson JH; Lagakos S; Stolbach L; Perlia CP; Bennett JM; Mansour EG; Horton J; Regelson W; Cummings FJ; Israel L; Brodsky I; Shnider BI; Creech R; Carbone PP
    Cancer Treat Rep; 1976 May; 60(5):625-7. PubMed ID: 186183
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer.
    Waterfield WC; Tashima CK; Hortobagyi GN; Blumenschein GR; Buzdar AU; Burgess MA
    Cancer; 1978 Apr; 41(4):1235-9. PubMed ID: 638989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.
    Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T
    Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467
    [No Abstract]   [Full Text] [Related]  

  • 14. "Total" therapy for oat cell carcinoma of the lung.
    Kent CH; Brereton HD; Johnson RE
    Int J Radiat Oncol Biol Phys; 1977; 2(5-6):427-32. PubMed ID: 195919
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary report of a cooperative randomized study for the treatment of localized small cell lung carcinoma.
    Seydel HG; Creech RH; Mietlowski WL; Perez CA
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1445-7. PubMed ID: 231592
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung: preliminary report of a cooperative trial.
    Cox JD; Petrovich Z; Paig C; Stanley K
    Cancer; 1978 Sep; 42(3):1135-40. PubMed ID: 212171
    [No Abstract]   [Full Text] [Related]  

  • 17. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination modality therapy in lung cancer: a survival study showing beneficial results of AMCOF (adriamycin, methotrexate, cyclophosphamide, oncovin and 5-fluorouracil).
    Reynolds RD; O'Dell S
    Cancer; 1978 Aug; 42(2):385-9. PubMed ID: 209881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An acceptable rate of complications in combined doxorubicin-irradiation for small cell carcinoma of the lung: A Southwest Oncology Group Study.
    Moore TN; Livingston R; Heilbrun L; Durrance FY; Tesh D; Hickman B; Bogardus C
    Int J Radiat Oncol Biol Phys; 1978; 4(7-8):675-80. PubMed ID: 213407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.